Nexium Buyers Fight Drugmakers' Bid For Costs After Loss
Nexium buyers who lost at trial in the pay-for-delay multidistrict litigation against AstraZeneca PLC and Ranbaxy Inc. have asked a federal court not to award the drugmakers more than $423,000 in...To view the full article, register now.
Already a subscriber? Click here to view full article